Extended cycle streptozotocin/5-FU chemotherapy for maintenance therapy in pancreatic neuroendocrine tumors.

Joerg Schrader Frank O Henes Michael Blaeker Katharina Zimmermann-Fraedrich Andrea Pace Daniel Perez-Camargo Jakob R Izbicki Ansgar Wilhelm Lohse Daniel Benten

Published in: Endocrine (2019)

Switching to an extended cycle protocol of 3 months for maintenance therapy following initial standard cycles may achieve long-term disease stabilization in selected patients with advanced pNET with good patient acceptance.

Keyphrases

neuroendocrine tumors
randomized controlled trial
case report
diabetic rats
locally advanced
metabolic syndrome
adipose tissue
radiation therapy
rectal cancer
skeletal muscle
replacement therapy